Drug Shortage Report for ATROPINE SULFATE INJECTION
Report ID | 111888 |
Drug Identification Number | 02426269 |
Brand name | ATROPINE SULFATE INJECTION |
Common or Proper name | ATROPINE SULFATE INJECTION |
Company Name | LABORATOIRE AGUETTANT |
Market Status | MARKETED |
Active Ingredient(s) | ATROPINE SULFATE |
Strength(s) | 0.5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS |
Packaging size | 10 syringes per box |
ATC code | A03BA |
ATC description | BELLADONNAAND DERIVATIVES, PLAIN |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2020-07-16 |
Actual start date | |
Estimated end date | |
Actual end date | 2020-07-16 |
Shortage status | Resolved |
Updated date | 2020-07-17 |
Company comments | COVID 19 has caused unprecedented drug demand and a potential risk of drug shortage. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1, RUE ALEXANDER FLEMING LYON, RHÔNE FRANCE 69007 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2020-07-17 | French | Compare |
v12 | 2020-07-17 | English | Compare |
v11 | 2020-07-16 | English | Compare |
v10 | 2020-07-09 | French | Compare |
v9 | 2020-07-09 | English | Compare |
v8 | 2020-07-06 | French | Compare |
v7 | 2020-07-06 | English | Compare |
v6 | 2020-06-26 | French | Compare |
v5 | 2020-06-26 | English | Compare |
v4 | 2020-04-27 | French | Compare |
v3 | 2020-04-27 | English | Compare |
v2 | 2020-04-12 | French | Compare |
v1 | 2020-04-12 | English | Compare |
Showing 1 to 13 of 13